Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,641.8 | 79.14 | 3,94,186.74 | 753.53 | 0.97 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,151.5 | 69.89 | 1,63,281.76 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,592.8 | 24.9 | 1,28,618.68 | 1,303.13 | 1 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,685.3 | 62.73 | 1,24,706.47 | 551 | 0.16 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,606.8 | 59.43 | 1,07,559.18 | 412.76 | 0 | 2,541.36 | 354.71 |
No Record Found
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.